ProNova Preps Its Next-Gen SC360 For Smaller, Cheaper Era Of Proton Therapy
This article was originally published in The Gray Sheet
Executive Summary
The system, which developers hope to launch in the U.S. in 2015 following completion of a 510(k) submission to FDA, will cost about $50 million for a two-room configuration, and the gantry will weigh 15 tons, well under the typical 110-220-ton weight of most systems, according to ProNova.